Alaunos Therapeutics | ZIOP - Umlaufvermögen





Umlaufvermögen Veränderung Datum
Alaunos Therapeutics USD 666K 304K 2026-06
Amgen USD 34.36B 598M 2026-09
AstraZeneca USD 31.45B 3.48B 2026-09
Baxter International USD 6.83B 163M 2026-09
Biogen USD 7.58B 278.7M 2026-09
Bioline Rx USD 16.35M 5.23M 2026-06
Bristol-Myers Squibb USD 29.77B 1.19B 2026-09
Celltrion KRW 493.66B 12.09B 2026-06
Corcept Therapeutics USD 533.87M 94.2M 2026-09
Cspc Pharmaceutical CNY 22.25B 359.48M 2025-12
Curis USD 16.61M 9.7M 2026-03
Deva Holding AS TRY 9.13B 1.61B 2023-09
Dianthus Therapeutics USD 856.04M 41.5M 2026-09
Divis Laboratories Ltd INR 124.39B 13.43B 2026-09
Gilead Sciences USD 16.55B 4.02B 2026-09
GlaxoSmithKline GBP 17.9B 336M 2026-09
Incyte USD 5.52B 505.2M 2026-09
Intrexon USD 23.72M 45.04M 2024-06
Ionis Pharmaceuticals USD 2.36B 129.77M 2026-09
J&J USD 56.35B 3.42B 2026-09
Kangmei Pharma CNY 6.66B 143.43M 2026-06
Karyopharm Therapeutics USD 126.33M 23.19M 2026-03
Knight Therapeutics CAD 394.84M 5.86M 2025-12
Laboratorios Farma EUR 509.33M 128.63M 2023-12
Malin Corporation EUR 62.6M 26.7M 2024-12
Medical Developments International AUD 33.75M 1.79M 2025-12
Merck USD 38.94B 2.26B 2026-09
Neuren Pharmaceuticals AUD 332.23M 11.98M 2025-12
Novartis USD 28.75B 1.4B 2026-09
Organigram Holdings CAD 280.09M 30M 2026-06
Ovoca Bio EUR 2.07M 510K 2025-12
Pfizer USD 45.01B 3.65B 2026-09
Pharma Mar EUR 295.56M 14.62M 2026-09
PTC Therapeutics USD 2.54B 79.58M 2026-09
Qiagen NV USD 1.66B 116.37M 2026-06
Regeneron Pharmaceuticals USD 20.8B 2.35B 2026-09
Roche Holding CHF 35.44B 3.29B 2026-06
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Sartorius EUR 1.65B 8.4M 2026-09
Sino Biopharmaceutical CNY 33.82B 9.13B 2025-06
TG Therapeutics USD 1.17B 25.76M 2026-09
Tilray USD 729.32M 28.18M 2025-09
Verastem USD 202.9M 20.51M 2026-03
Zealand Pharma A/S 15.02B 652.12M 2026-03
Zz Pientze Pharmaceu CNY 13.48B 2.32B 2026-09